XVALO Vale S.A.
Vale S.A., together with its subsidiaries, produces iron ore and nickel in Brazil, Asia, the Middle East, North Africa, Europe, the Americas, and Oceania. The company operates in two segments, Iron Ore Solutions and Vale Base Metals. It extracts, produces, and distributes iron ore, iron ore pellets, briquettes, nickel, copper, other ferrous products, and by-products, including gold, silver, cobalt, platinum-group metals, and other base metals, as well as low-carbon critical minerals. The company also operates logistics systems and distribution centers, such as mining complexes, railways, and maritime terminals, ports, and ships; generates energy from hydroelectric, solar, and wind sources; and engages in greenfield mineral exploration. In addition, it is involved in research; and trading activities. The company was formerly known as Companhia Vale do Rio Doce and changed its name to Vale S.A. in May 2009. Vale S.A. was founded in 1942 and is headquartered in Rio De Janeiro, Brazil.…
Industry Peers
Other Industrial Metals & MiningKey Statistics
About Vale (BME: XVALO)
›
Vale (BME: XVALO) is listed on the Bolsa de Madrid, where its shares trade in EUR. It belongs to the Other Industrial Metals & Mining industry, part of the Basic Materials sector, and reports about 65,805 employees.
The shares were at 9.385 EUR on 19 November 2026, up 55.4% over 52 weeks. Its 52-week range is 9.200 EUR to 15.01 EUR: the price is 37.5% below the high and 2.0% above the low.
At a market capitalisation of 39.60B EUR, it trades at 66.5 times trailing earnings. The median trailing P/E of its 16 largest Other Industrial Metals & Mining peers is 11.9, a premium of 457% for XVALO. It pays a dividend yielding 7.56%, against a median of 2.99% among the dividend payers in that peer group.
Vale reports return on equity of 7.0%, an operating margin of 24.4% and revenue down 3.9% year over year.
Its debt exceeds its cash by 83.86B BRL, a debt-to-equity ratio of 0.65. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. The next earnings report is expected on 11 February 2027.